Sage Therapeutic
Biotechnology
Healthcare
SAGE
61.86 M shares
NASDAQ US
traded
30 Jul 2025
listed
no
open
8.74
52 week high
13.08
high
8.74
52 week low
0.00
previous Close
8.70
P/E ratio
market cap
569 M
div yield
0
net incoming
-62.21 M
35.04 %
net profit margin
-442.39 %
304.00 %
operating incoming
-67.46 M
33.99 %
net change in cash
-35.80 M
-79.09 %
cash on hand
45.22 M
-44.18 %
cost of revenue
655 K
-56.01 %
top